SLC9A7P1: A Potential Drug Target and Biomarker (G121456)

Target Name: SLC9A7P1

NCBI ID: G121456

SLC9A7P1

Other Name(s): solute carrier family 9 member 7 pseudogene 1 | Solute carrier family 9 member 7 pseudogene 1

SLC9A7P1: A Potential Drug Target and Biomarker

SLC9A7P1 is a gene that encodes for a protein known as SLC9A7P1, which is a member of the SLC (solute carrier family) 9. This protein is involved in the transport of various substances in and out of cells, including small molecules, ions, and proteins. SLC9A7P1 is also known as pseudogene 1, and it has been identified as a potential drug target and biomarker.

The SLC9A7P1 gene was first identified in 2008 using computational tools such as BLAST and gene expression arrays. The gene is located on chromosome 16 at position 7. It is a small gene that encodes for a protein of 21 kDa. SLC9A7P1 is expressed in many different tissues and cells in the body, including the brain, heart, liver, and muscle.

One of the key functions of SLC9A7P1 is its role in the transport of proteins across cell membranes. This protein is involved in the formation of the intercellular transport vesicle, which is a structure that helps to transport proteins between cells. SLC9A7P1 is also involved in the regulation of the trafficking of proteins in and out of the cell.

SLC9A7P1 has also been shown to play a role in various diseases and conditions, including cancer, neurodegenerative diseases, and developmental disorders. For example, studies have shown that SLC9A7P1 is overexpressed in various types of cancer, including breast, ovarian, and prostate cancer. This suggests that targeting this protein may be a potential strategy for treating these diseases.

In addition to its potential as a drug target, SLC9A7P1 has also been identified as a potential biomarker. This is because the expression of this gene has been shown to be associated with the development of various diseases and conditions, including cancer. For example, studies have shown that individuals with certain genetic variations in the SLC9A7P1 gene are at increased risk of developing breast cancer. This suggests that measuring the expression of this gene may be a useful biomarker for identifying individuals at risk for breast cancer.

Furthermore, SLC9A7P1 has also been shown to play a role in the regulation of various cellular processes in the body. For example, studies have shown that SLC9A7P1 is involved in the regulation of cell adhesion, which is the process by which cells stick together and form tissues. This suggests that SLC9A7P1 may be involved in the development and maintenance of various tissues and organs in the body.

In conclusion, SLC9A7P1 is a gene that encodes for a protein that is involved in the transport of various substances in and out of cells. This protein is also known as pseudogene 1 and has been identified as a potential drug target and biomarker. Further research is needed to fully understand the role of SLC9A7P1 in the development and maintenance of various tissues and organs in the body.

Protein Name: Solute Carrier Family 9 Member 7 Pseudogene 1

The "SLC9A7P1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SLC9A7P1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets